Proteon Therapeutics is committed to improving the health of patients with kidney and vascular diseases through the development of novel, first-in-class therapeutics

from http://www.proteontherapeutics.com/

Research Grants show all

NIH2

Publications show all

Proteon Therapeutics has published 7 articles.

Patents show all

35Applications29Issued

Clinical Trials show all

3Phase 12Phase 1/Phase 22Phase 31Phase 2

SEC Filings show all

8-K3010-Q8D410-K3S-11

Private Funding Events

DateOfferedSoldType
2014-05-28$29,565,934$29,565,934Equity
2014-02-19$4,338,660$4,338,660Equity, Debt, Option to Acquire
2011-08-11$15,183,371$15,183,371Equity, Option to Acquire
2009-03-11UnknownUnknownOther (Paper Filing)

Key Executives

  • Timothy Noyes
    Executive Officer, Director
  • F. Nicholas Franano
    Director
  • Brendan O'Leary
    Director
  • Gregory D. Phelps
    Director
  • David G. Lowe
    Director
  • Hubert Birner
    Director
  • Steven St. Peter
    Director
  • Dean Profis
    Executive Officer
  • Stephen Hoffman
    Director
  • Todd Foley
    Director
  • Tim Haines
    Director
  • Dmitry Kobyzev
    Director
  • John G. Freund
    Director
  • Steven K. Burke
    Executive Officer
  • Daniel P. Gottlieb
    Executive Officer
  • George Eldridge
    Executive Officer